317 related articles for article (PubMed ID: 32606719)
1. Understanding Erectile Dysfunction in Hypertensive Patients: The Need for Good Patient Management.
Hernández-Cerda J; Bertomeu-González V; Zuazola P; Cordero A
Vasc Health Risk Manag; 2020; 16():231-239. PubMed ID: 32606719
[TBL] [Abstract][Full Text] [Related]
2. Update of the position paper on arterial hypertension and erectile dysfunction.
Viigimaa M; Vlachopoulos C; Doumas M; Wolf J; Imprialos K; Terentes-Printzios D; Ioakeimidis N; Kotsar A; Kiitam U; Stavropoulos K; Narkiewicz K; Manolis A; Jelakovic B; Lovic D; Kreutz R; Tsioufis K; Mancia G;
J Hypertens; 2020 Jul; 38(7):1220-1234. PubMed ID: 32073535
[TBL] [Abstract][Full Text] [Related]
3. Pharmacotherapeutic management of erectile dysfunction.
Hawksworth DJ; Burnett AL
Clin Pharmacol Ther; 2015 Dec; 98(6):602-10. PubMed ID: 26352006
[TBL] [Abstract][Full Text] [Related]
4. Erectile dysfunction diagnosis and treatment as a means to improve medication adherence and optimize comorbidity management.
Scranton RE; Goldstein I; Stecher VJ
J Sex Med; 2013 Feb; 10(2):551-61. PubMed ID: 23153075
[TBL] [Abstract][Full Text] [Related]
5. Pharmacology and perspectives in erectile dysfunction in man.
Mitidieri E; Cirino G; d'Emmanuele di Villa Bianca R; Sorrentino R
Pharmacol Ther; 2020 Apr; 208():107493. PubMed ID: 31991196
[TBL] [Abstract][Full Text] [Related]
6. Erectile Dysfunction as a Cardiovascular Risk Factor: Time to Step Up?
Imprialos K; Koutsampasopoulos K; Manolis A; Doumas M
Curr Vasc Pharmacol; 2021; 19(3):301-312. PubMed ID: 32286949
[TBL] [Abstract][Full Text] [Related]
7. Effect of irbesartan on erectile function in patients with hypertension and metabolic syndrome.
Baumhäkel M; Schlimmer N; Böhm M;
Int J Impot Res; 2008; 20(5):493-500. PubMed ID: 18596705
[TBL] [Abstract][Full Text] [Related]
8. Sexual function in hypertensive patients receiving treatment.
Reffelmann T; Kloner RA
Vasc Health Risk Manag; 2006; 2(4):447-55. PubMed ID: 17323599
[TBL] [Abstract][Full Text] [Related]
9. Two Birds with One Stone: Regular Use of PDE5 Inhibitors for Treating Male Patients with Erectile Dysfunction and Cardiovascular Diseases.
Cai Z; Zhang J; Li H
Cardiovasc Drugs Ther; 2019 Feb; 33(1):119-128. PubMed ID: 30675707
[TBL] [Abstract][Full Text] [Related]
10. Newer phosphodiesterase inhibitors: comparison with established agents.
McNamara ER; Donatucci CF
Urol Clin North Am; 2011 May; 38(2):155-63. PubMed ID: 21621082
[TBL] [Abstract][Full Text] [Related]
11. Management of Erectile Dysfunction: An Under-Recognition of Hypertension.
Koroglu G; Kaya-Sezginer E; Yilmaz-Oral D; Gur S
Curr Pharm Des; 2018; 24(30):3506-3519. PubMed ID: 30152279
[TBL] [Abstract][Full Text] [Related]
12. Tadalafil once daily in men with erectile dysfunction: an integrated analysis of data obtained from 1913 patients from six randomized, double-blind, placebo-controlled, clinical studies.
Porst H; Gacci M; Büttner H; Henneges C; Boess F
Eur Urol; 2014 Feb; 65(2):455-64. PubMed ID: 24119319
[TBL] [Abstract][Full Text] [Related]
13. Evaluation and Management of Erectile Dysfunction in the Hypertensive Patient.
Patel JP; Lee EH; Mena-Hurtado CI; Walker CN
Curr Cardiol Rep; 2017 Aug; 19(9):89. PubMed ID: 28836189
[TBL] [Abstract][Full Text] [Related]
14. Erectile Dysfunction.
Rew KT; Heidelbaugh JJ
Am Fam Physician; 2016 Nov; 94(10):820-827. PubMed ID: 27929275
[TBL] [Abstract][Full Text] [Related]
15. Antihypertensive Drugs and Male Sexual Dysfunction: A Review of Adult Hypertension Guideline Recommendations.
Al Khaja KA; Sequeira RP; Alkhaja AK; Damanhori AH
J Cardiovasc Pharmacol Ther; 2016 May; 21(3):233-44. PubMed ID: 26450998
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide, erectile dysfunction and beta-blocker treatment (MR NOED study): benefit of nebivolol versus metoprolol in hypertensive men.
Brixius K; Middeke M; Lichtenthal A; Jahn E; Schwinger RH
Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):327-31. PubMed ID: 17324145
[TBL] [Abstract][Full Text] [Related]
17. A systematic review of the psychosocial outcomes associated with erectile dysfunction: does the impact of erectile dysfunction extend beyond a man's inability to have sex?
McCabe MP; Althof SE
J Sex Med; 2014 Feb; 11(2):347-63. PubMed ID: 24251371
[TBL] [Abstract][Full Text] [Related]
18. Study of the risk factors of erectile dysfunction and phospho diestrase type 5 inhibitors usage among Egyptian population with erectile dysfunction: A cross-sectional survey.
Elnaser Mohamed TA; Kamel II; Abdelaal AMA; Mohammad AF; GamalEl Din SF
Rev Int Androl; 2021; 19(4):249-258. PubMed ID: 33773939
[TBL] [Abstract][Full Text] [Related]
19. Erectile dysfunction in the cardiac patient: how common and should we treat?
Kloner RA; Mullin SH; Shook T; Matthews R; Mayeda G; Burstein S; Peled H; Pollick C; Choudhary R; Rosen R; Padma-Nathan H
J Urol; 2003 Aug; 170(2 Pt 2):S46-50; discussion S50. PubMed ID: 12853773
[TBL] [Abstract][Full Text] [Related]
20. BPH/LUTS and ED: common pharmacological pathways for a common treatment.
Fusco F; D'Anzeo G; Sessa A; Pace G; Rossi A; Capece M; d'Emmanuele di Villa Bianca R
J Sex Med; 2013 Oct; 10(10):2382-93. PubMed ID: 23875757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
